Noninvasive linear accelerator radiosurgery as the primary treatment for trigeminal neuralgia

L Frighetto1, A A De Salles, Z A Smith

  • 1Division of Neurosurgery, School of Medicine, University of California, Los Angeles, CA, USA.

Neurology
|February 26, 2004
PubMed

Insights

Dedicated linear accelerator (DLINAC) radiosurgery offers effective, noninvasive treatment for trigeminal neuralgia. This study shows DLINAC radiosurgery provides significant pain relief for most patients as a primary treatment.

Area of Science:

  • Neurosurgery
  • Radiation Oncology

Background:

  • Trigeminal neuralgia is a debilitating neuropathic pain condition.
  • Noninvasive surgical options are sought for essential trigeminal neuralgia treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of dedicated linear accelerator (DLINAC) radiosurgery.
  • To assess DLINAC radiosurgery as a primary treatment for essential trigeminal neuralgia.

Main Methods:

  • Retrospective analysis of 22 patients with essential trigeminal neuralgia.
  • Treatment with DLINAC radiosurgery as a primary intervention.

Main Results:

  • Significant pain relief was achieved in 21 out of 22 patients (95.5%) at the last follow-up.
  • DLINAC radiosurgery demonstrated a high success rate in pain management.

Conclusions:

  • DLINAC radiosurgery is a safe and effective primary treatment option.
  • Selected patients with essential trigeminal neuralgia can benefit from DLINAC radiosurgery.

Related Concept Videos